Working... Menu

Phase 2 Study of EPI-743 for Treatment of Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01822249
Recruitment Status : Completed
First Posted : April 2, 2013
Last Update Posted : July 25, 2018
Information provided by (Responsible Party):
Edison Pharmaceuticals Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : January 2014